Effect of stem cell source on long-term chimerism and event-free survival in children with primary immunodeficiency disorders after fludarabine and melphalan conditioning regimen - 06/10/16
, Stuart Adams, PhD a, Waseem Qasim, MD, PhD a, b, Zoe Allwood, BSc, MPH a, Austen Worth, MRCP, MD, PhD a, b, Juliana Silva, MD a, Giovanna Lucchini, MD a, Robert Chiesa, MD a, Paul Veys, FRCP, FRCPath a, Persis Amrolia, PhD, FRCP, FRCPath a, bAbstract |
Background |
Reduced-intensity conditioning (RIC) regimens are increasingly being used in the transplantation of patients with primary immunodeficiency disorders (PIDs), but there are no large studies looking at long-term lineage-specific chimerism.
Objectives |
We sought to analyze long-term chimerism and event-free survival in children undergoing transplantation for PIDs using RIC with fludarabine and melphalan (Flu/Melph) and to study the effect of donor type and stem cell source.
Methods |
One hundred forty-two children underwent transplantation with RIC by using Flu/Melph and for PIDs by using bone marrow (n = 93) or peripheral blood stem cells (PBSCs; n = 49). Donors were matched unrelated donors (n = 72), mismatched unrelated donors (n = 37), matched sibling donors (n = 14), matched family donors (n = 12), and mismatched family donors (n = 7).
Results |
Overall survival at a median follow-up of 7.5 years was 78%, irrespective of stem cell source or donor type. When bone marrow was used as the stem cell source, 26% of patients ended up with very low levels of donor chimerism (<10% donor), especially in the myeloid lineage. Event-free survival in this group was significantly lower compared with that in the rest of the group (25% vs 70%, P < .001). With the use of PBSCs, more than 90% of patients achieved complete donor chimerism or high-level mixed chimerism (>50% donor chimerism) in all lineages.
Conclusions |
On the basis of our experience, we would suggest that PBSCs should be the stem cell source of choice in children with PIDs undergoing transplantation with Flu/Melph RIC from a matched donor source. This is most likely to ensure sustained high-level donor chimerism.
Le texte complet de cet article est disponible en PDF.Key words : Primary immunodeficiency disorder, hematopoietic stem cell transplantation, chimerism, lineage specific, reduced intensity
Abbreviations used : aGVHD, BM, CC, cGVHD, DLI, Flu/Melph, GVHD, HSCT, MC, MFD, MMF, mMFD, mMUD, MSD, MUD, PBSC, PID, RIC, SCID
Plan
| Supported by the National Institute for Health Research (NIHR) through the Great Ormond Street Hospital Biomedical Research Centre. P.A. is a recipient of an NIHR Research Professorship. |
|
| Disclosure of potential conflict of interest: W. Qasim has consultant arrangements with Autolus and Servier; has received grants from Cellectis SA, Miltenyi Biotec, Cellmedica, Bellicum, and Autolus; has stock/stock options in Autolus; and has received travel support from Miltenyi Biotec. The rest of the authors declare that they have no relevant conflicts of interest. |
Vol 138 - N° 4
P. 1152-1160 - octobre 2016 Retour au numéro
Article précédent
- Rapid molecular diagnostics of severe primary immunodeficiency determined by using targeted next-generation sequencing
- Hui Yu, Victor Wei Zhang, Asbjørg Stray-Pedersen, Imelda Celine Hanson, Lisa R. Forbes, M. Teresa de la Morena, Ivan K. Chinn, Elizabeth Gorman, Nancy J. Mendelsohn, Tamara Pozos, Wojciech Wiszniewski, Sarah K. Nicholas, Anne B. Yates, Lindsey E. Moore, Knut Erik Berge, Hanne Sorte, Diana K. Bayer, Daifulah ALZahrani, Raif S. Geha, Yanming Feng, Guoli Wang, Jordan S. Orange, James R. Lupski, Jing Wang, Lee-Jun Wong
- Dysregulation of proinflammatory versus anti-inflammatory human TH17 cell functionalities in the autoinflammatory Schnitzler syndrome
- Rebecca Noster, Heleen D. de Koning, Elisabeth Maier, Martina Prelog, Elke Lainka, Christina E. Zielinski
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?